INZY
Price
$1.51
Change
-$0.21 (-12.21%)
Updated
Jan 14 closing price
Capitalization
97M
64 days until earnings call
PSTX
Price
$9.50
Change
-$0.06 (-0.63%)
Updated
Jan 7 closing price
Capitalization
925.93M
50 days until earnings call
Ad is loading...

INZY vs PSTX

Header iconINZY vs PSTX Comparison
Open Charts INZY vs PSTXBanner chart's image
Inozyme Pharma
Price$1.51
Change-$0.21 (-12.21%)
Volume$1.54M
Capitalization97M
Poseida Therapeutics
Price$9.50
Change-$0.06 (-0.63%)
Volume$21.42M
Capitalization925.93M
INZY vs PSTX Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INZY vs. PSTX commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a StrongBuy and PSTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (INZY: $1.51 vs. PSTX: $9.50)
Brand notoriety: INZY and PSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 207% vs. PSTX: 510%
Market capitalization -- INZY: $97M vs. PSTX: $925.93M
INZY [@Biotechnology] is valued at $97M. PSTX’s [@Biotechnology] market capitalization is $925.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $374.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 1 FA rating(s) are green whilePSTX’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 1 green, 4 red.
  • PSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both INZY and PSTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 1 TA indicator(s) are bullish while PSTX’s TA Score has 3 bullish TA indicator(s).

  • INZY’s TA Score: 1 bullish, 3 bearish.
  • PSTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both INZY and PSTX are a bad buy in the short-term.

Price Growth

INZY (@Biotechnology) experienced а -46.45% price change this week, while PSTX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.85%. For the same industry, the average monthly price growth was -2.06%, and the average quarterly price growth was -3.70%.

Reported Earning Dates

INZY is expected to report earnings on May 13, 2025.

PSTX is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-6.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSTX($926M) has a higher market cap than INZY($97M). PSTX YTD gains are higher at: -1.042 vs. INZY (-45.487). PSTX has higher annual earnings (EBITDA): -46.16M vs. INZY (-90.3M). PSTX has more cash in the bank: 231M vs. INZY (132M). INZY has less debt than PSTX: INZY (46.8M) vs PSTX (82.7M). PSTX has higher revenues than INZY: PSTX (151M) vs INZY (0).
INZYPSTXINZY / PSTX
Capitalization97M926M10%
EBITDA-90.3M-46.16M196%
Gain YTD-45.487-1.0424,367%
P/E RatioN/AN/A-
Revenue0151M-
Total Cash132M231M57%
Total Debt46.8M82.7M57%
TECHNICAL ANALYSIS
Technical Analysis
INZYPSTX
RSI
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
Stochastic
ODDS (%)
N/A
Bearish Trend 8 days ago
80%
Momentum
ODDS (%)
Bearish Trend 8 days ago
88%
Bullish Trend 8 days ago
82%
MACD
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
88%
Bearish Trend 8 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 8 days ago
84%
Advances
ODDS (%)
Bullish Trend 13 days ago
86%
Bullish Trend 10 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 28 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
72%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JABIX12.030.09
+0.75%
JHancock Real Estate Securities R6
QDVIX12.300.07
+0.57%
EquityCompass Quality Dividend Instl
PAADX15.900.04
+0.25%
Putnam Dynamic Asset Allocation Bal R5
JAGRX58.77N/A
N/A
Janus Henderson VIT Research Instl
LCMMX74.51-0.22
-0.29%
ClearBridge Large Cap Growth O

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with IGMS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then IGMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-12.21%
IGMS - INZY
53%
Loosely correlated
-3.66%
BEAM - INZY
51%
Loosely correlated
-8.77%
DNLI - INZY
48%
Loosely correlated
-4.34%
NTLA - INZY
48%
Loosely correlated
-3.13%
NAUT - INZY
47%
Loosely correlated
+1.09%
More

PSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with QNRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then QNRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTX
1D Price
Change %
PSTX100%
N/A
QNRX - PSTX
48%
Loosely correlated
+0.07%
ALEC - PSTX
46%
Loosely correlated
-8.66%
EDIT - PSTX
42%
Loosely correlated
-1.72%
PGEN - PSTX
42%
Loosely correlated
+1.40%
ABCL - PSTX
41%
Loosely correlated
-7.67%
More